Thirteen people have been infected with Vibrio vulnificus, the so-called "fleshing-eating" bacteria, according to a report.

Bristol Myers Squibb acknowledged that a phase III trial of luspatercept (Reblozyl) plus a Janus kinase inhibitor for ...

Cancer patients along the Alabama Gulf coast will have another treatment option. U-S-A Health will soon be the first hospital system in the state to use a new technique that uses ultrasound energy to ...

Background Steatotic liver disease-related hepatocellular carcinoma (SLD-HCC), a rising global challenge, is characterised by ...